GSK plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. Modern Slavery Act statement 2022 (PDF - 189.7KB) GSK websites Locations selector GSKPro for healthcare professionals GSK study register Supplier...
© 2001-2024 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG > Modern Slavery Act statement 2023 (PDF -...
(Registered number: 81761198) Annual Report and Financial Statements for the year ended 31 December 2022 Registered office address: 980 Great West Road Brentford Middlesex TW8 9GS England UK trading office address: 980 Great West Road Brentford Middlesex TW8 9GS England GSK Capital B.V. (...
GSK plc. Registered in England and Wales No. 3888792.Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DGGSK websites GSK Global website Locations selector Global Behind the science GSKPro for HCPs ViiV Healthcare GSK study register Business to Business Quick...
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered the development of a novel class of vaccines, the most advanced of which are next...
GSK Pakistan Annual Report 2024 Quarterly results You might also like Our products We research and develop a broad range of innovative products Pharmaceuticals and Vaccines Career opportunities at GSK Discover the work we do and the opportunities that exist, from research and development through to ma...
Past dividends on GSK plc 2025-02-19Final Payment 0.16 GBP 2024-11-13Interim Payment 0.15 GBP 2024-08-14Interim Payment 0.15 GBP 2024-05-15Interim Payment 0.15 GBP Annual results Quarterly results Quarterly revenue - Rate of surprise
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered the development of a novel class of vaccines, the most advanced of which are next...
GlaxoSmithKline plc is one of the leading pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. In 2024, the company generated a total of some 31.4 billion British pounds of revenue, compared to 30.3 billion in 2023. The lower revenue figures from 2022 on ...
GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 GSK plc at a glance Our purpose We unite science, technology and talent to get ahead of disease together For health impact + shareholder returns + thriving people About our new logo The new logo reflects our new purpose and growth ...